Skip to main content
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 2005 Oct 26;77(6):958–965. doi: 10.1086/498174

Preferential Transmission of Paternal Alleles at Risk Genes in Attention-Deficit/Hyperactivity Disorder

Ziarih Hawi 1, Ricardo Segurado 1, Judith Conroy 1, Karen Sheehan 1, Naomi Lowe 1, Aiveen Kirley 1, Denis Shields 1, Michael Fitzgerald 1, Louise Gallagher 1, Michael Gill 1
PMCID: PMC1285179  PMID: 16380908

Abstract

Family, twin, and adoption studies have demonstrated a significant genetic contribution to the etiology of attention-deficit/hyperactivity disorder (ADHD). Pharmacological, neuroimaging, and animal-model findings suggest imbalances in monoaminergic (dopaminergic, serotonergic, and noradrenergic) neurotransmission in ADHD. We have examined monoaminergic candidate genes for possible genetic association with ADHD in the Irish population, focusing particularly on genes of the dopaminergic and serotonergic systems. We have observed that several of these genes are associated with ADHD, including DAT1, DBH, DRD4, DRD5, and 5HT1B. Here, we present what appears to be a systematic overtransmission of paternal alleles at candidate genes associated with ADHD. For the nine genes included in the analysis, the overall odds ratio for paternal transmission was 2, compared with 1.3 for maternal transmission (paternal vs. maternal χ2=9.6; P=.0019). Transmission to females, from either parent, was significantly stronger than to males. Possible reasons for this preferential transmission include imprinting and ascertainment bias, although results of further analyses show that the latter is unlikely.

Introduction

Attention-deficit/hyperactivity disorder (ADHD [MIM 143465]) is one of the most prevalent syndromes, which affects 2%–6% of school-age children. It is typically characterized by inattention, excessive motor activity, impulsivity, and distractibility. Individuals with ADHD have significant impairment in family and peer relations and in academic functioning and are at increased risk of drug abuse and dangerous behavior, such as reckless driving (Mannuzza et al. 1993; Nada-Raja et al. 1997). Family, twin, and adoption studies demonstrate the importance of genetic factors in predisposition to ADHD. Relatives of patients have a higher morbidity risk (25.3%) for the disorder compared with relatives of control individuals (4.6%) (Biederman et al. 1992). Heritability is estimated to be 39%–91% (Thapar et al. 1999). On the basis of symptom scores, ADHD was classified into three major subtypes: the combined (50%–75%), inattentive (20%–30%), and hyperactive (<15%) subtypes (Wilens et al. 2002).

Boys are more frequently affected with the disorder than are girls, with observed ratios that range from 2:1–4:1 in population-based surveys to 9:1 in clinical studies (Ford et al. 2003; Poeta and Rosa Neto 2004). Although well documented in the literature of ADHD, the causes of sex differences are unknown; however, a multiple-threshold model has been proposed. In this model, the cause of ADHD was assumed to be polygenic factors (more than one gene involved) in combination with environmental factors. In this context, individuals differ in the amount of liability that they have for the disorder. The development of the disorder depends on whether the individual exceeds a given threshold of liability (Rhee et al. 1999). According to this model, female probands would require a greater liability than would male probands. This model therefore predicts that the rate of the disorder would be higher in the relatives of female probands than those of male probands. Evidence to support the polygenic multiple-threshold model for ADHD was reported by Kashani et al. (1979) and Faraone et al. (1995). Girls with ADHD are less likely than boys to develop major depression, learning disabilities, conduct disorder, and oppositional defiant disorder (Biederman et al. 2002). This may result in boys being referred for assessment more frequently than girls. Furthermore, because the symptoms of inattention (more prevalent in girls) are more covert than those of hyperactivity and impulsivity (more common in boys), fewer girls than boys might be diagnosed with the disorder (Biederman and Faraone 2004).

Pharmacological, neuroimaging, and animal-model findings suggest the importance of imbalance in monoaminergic neurotransmission in ADHD. This has also been supported by recent genetic association studies (Hawi et al. 2003). The focus of most molecular studies (association/linkage) has been on the genes of the dopaminergic and, to lesser extent, the serotonergic systems. However, genes relating to the noradrenergic and glutaminergic systems are also under investigation.

To date in our studies, we have investigated 17 candidate genes for ADHD, focusing on monoaminergic system genes, particularly dopaminergic and serotonergic (table 1). The results of these studies have been the subject of several publications that describe evidence for association at DAT1 (MIM 126455), DBH (MIM 609312), DRD4 (MIM 126452), DRD5 (MIM 126453), 5HT1B (MIM 182131), SNAP25 (MIM 600322), and TPH2 (MIM 607478) (see Daly et al. 1999; Brophy et al. 2002; Hawi et al. 2002; Lowe et al. 2004a; Sheehan et al. 2005).

Table 1.

TDT Analysis of Candidate Genes Examined in the Study Sample

System and Gene No. ofExaminedMarkers χ2 P
Dopaminergic:
 Dopamine receptor 1 (DRD1) 1 .17 .78
 Dopamine receptor 2 (DRD2) 2 .57 .57
 Dopamine receptor 3 (DRD3) 1 .1 .87
 Dopamine receptor 4 (DRD4) 5 7.5 .008
 Dopamine receptor 5 (DRD5) 5 11.1 .001
 Dopamine transporter (DAT1) 5 1.2 .4
 Catechol-O-methytransferase (COMT) 1 .06 .87
 Tyrosine hydroxylase (TH) 1 4.4 .04
 Dopamine beta hydroxylase (DBH) 4 1.2 .31
 Dopa decarboxylase (DDC) 3 4.2 .098
 Synaptosomal-associated protein 25 (SNAP-25) 7 2.7 .12
Serotonergic:
 Serotonin receptor 1B (5HT1B) 3 1.9 .2
 Serotonin receptor 2A (5HT2A) 2 .64 .5
 Serotonin transporter (SERT) 4 3.6 .08
 Tryptophan hydroxylase 2 (TPH2) 8 12.1 .0006
Noradrenergic:
 Noradrenaline transporter (NET) 2 2.3 .17
Glutamatergic:
 N-methyl-d-aspartate receptor 2A subunit (GRIN2A) 1 .03 .9

It is evident that ADHD is a heterogeneous and genetically complex disorder, with several genes (each of minor or moderate effect) involved in the etiology of the syndrome. Overall, the literature supports DRD4, DRD5, and DAT1 as susceptibility loci for ADHD (Faraone et al. 2001, 2005; Maher et al. 2002; Lowe et al. 2004b).

In our individual gene studies, we have observed what appears to be a consistent pattern of preferential paternal transmission of risk alleles to affected children with ADHD. In this work, we investigated our observations in a more systematic manner. In particular, we examined paternal versus maternal transmission for all studied genes in the Irish ADHD sample, for “associated” genes (see definition in the “Material and Methods” section), for transmission to male versus female children, and for transmission from “affected” (see definition in the “Material and Methods” section) versus unaffected parents.

Material and Methods

Subjects

A total of 179 Irish ADHD-affected nuclear families were included in the current study. The sample was ascertained and the diagnosis confirmed as described elsewhere (Kirley et al. 2004). In brief, consensus diagnoses were made in accordance with DSM-IV criteria. One or both parents of each child were interviewed using the Child and Adolescent Psychiatric Assessment. To fulfill DSM-IV criteria for symptom pervasiveness, information about ADHD symptoms at school was obtained from teachers through use of the Teacher Telephone Interview, which involved asking teachers about DSM-IV symptoms of ADHD and impairment shown in class. In addition, 155 Irish autistic nuclear families (probands and both parents) were recruited through schools and parent support groups. Subjects were assessed by use of the Autism Diagnostic Interview–Revised (Lord et al. 1989) and the Autism Diagnostic Observation Schedule–Generic (Lord et al. 2000) and were used as a comparative group, since autism (MIM 209850) exhibits a similar male:female ratio. Of the sample, 77% were affected with ADHD–combined type, whereas 15% met research criteria for ADHD–inattentive type, and 8% for ADHD–hyperactive-impulsive type.

Genotyping Methods

PCR-based genotyping of markers included in this study was conducted using the primer sequences and amplification conditions as described and referenced in table 2.

Table 2.

Marker Names, PCR Primers, and Amplification Conditions

Primer Sequences
System and Gene (Marker) Database Identification Forward Reverse Additional Information
Dopaminergic:
DRD1 rs265981a 5′-CTCTCGAAAGGAAGCCAAGA-3′ 5′-CGGCTCCGAAACGTTGAG-3′ Cichon et al. 1996
DRD2 (TaqI) rs1800497a 5′-GGCTTAGAACCACCCAGAGT-3′ 5′-AGAGCAGTCAGGCTGGACAC-3′ 30 cycles at 95°C for 60 s, 64°C for 60 s, and 72°C for 60 s
DRD3 rs6280a 5′-GCTCTATCTCCAACTCTCACA-3′ 5′-AAGTCTACTCACCTCCAGGTA-3′ Hawi et al. 1998
DRD4 (-616) rs12720373a 5′-GTTGTCTGTCTTTTCTCATTGTTTCCATTG-3′ 5′-GAAGGAGCAGGCCCAGTGAGC-3′ Barr et al. 2001
DRD5 (CA)n PCR-1 (GDBb 270166) 5′-CGTGTATGATCCCTGCAG-3′ 5′-GCTCATGAGAAGAATGGAGTG-3′ Daly et al. 1999
DAT1 (3′ VNTR) GDBb 161500 5′-TGTGGTGTAGGGAACGGCCTGAG-3′ 5′-CTTCCTGGAGGTCACGGCTCAAGG-3′ Gill et al. 1997
COMT rs4680a 5′-ACTGTGGCTACTCAGCTGTG-3′ 5′-CCTTTTTCCAGGTCTGACAA-3′ Hawi et al. 2000
TH (TCAT)n HUMTH01 (GDBb 180306) 5′-GGCAAATAGGGGGCAAAA-3′ 5′-GGCTTCCGAGTGCAGGTC-3′ 30 cycles at 92°C for 30 s, 56°C for 30 s, and 72°C for 30 s
DBH (TaqI) rs2519152a 5′-CTGTATTTGGAACTTGGCATC-3′ 5′-AGGCATTTTACTACCCAGAGG-3′ Daly et al. 1999
DDC (insAGAG) GenBankc M77828 5′-GAGGGATGCTGCTCAGTAAA-3′ 5′-ATCCAGAGAGCTGGACGC-3′ Speight et al. 2000
SNAP-25 (MnlI) rs3746544a 5′-TTCTCCTCCAAATGCTGTCG-3′ 5′-CCACCGAGGAGAGAAAATGAAA-3′ Barr et al. 2000
Serotonergic:
5HT1B (861G) rs6296a 5′-GAAACAGACGCCCAACAGGAG-3′ 5′-CCAGAAACCGCGAAAGAAGAT-3′ Hawi et al. 2002
5HT2A (His/Tyr) rs6314a 5′-CACACAGCTCACCTTTTCATTCA-3′ 5′-AGTCTAGCCAACTTCAAATGG-3′ Hawi et al. 2002
SERT D17S1294 5′-TGGCATGCAATTGTAGTCTC-3′ 5′-TTCTTTCCTTACTAAGTTGAGAACG-3′ 35 cycles at 94°C for 1 min, 55°C for 1 min, and 72°C for 1 min
TPH2 rs1843809a 5′-AAAGAGGCCCTGAGCTCCTA-3′ 5′-CATGAGGTTCATGGGCTACC-3′ Sheehan et al. 2005
Noradrenergic:
NET rs5568a 5′-CAGCCATTGATGAGGTCATTG-3′ 5′-CACTGTGTGTTGGGGAAGG-3′ Stober et al. 1996
Glutamatergic:
GRIN2A rs8049651a 5′-TTGCCTCTCCAGAAATCAGC-3′ 5′-CATGCTATTTCAAAGGGTTGG-3′ Turic et al. 2004

Transmission/Disequilibrium Test

The transmission/disequilibrium test (TDT) is a linkage and family-based association test (Spielman et al. 1993) designed to avoid errors in case-control studies that are due to population stratification. It compares the frequency of transmitted and nontransmitted alleles from parents heterozygous for a given polymorphism.

Definition of ADHD History–Positive Parents

Parents completed the Wender Utah Rating Scale (WURS) (Ward et al. 1993) to retrospectively determine the presence and extent of ADHD symptoms and behaviors during their childhood. WURS consists of a 25-item subscale in which a cutoff score of ⩾36 is 96% sensitive and specific for a retrospective diagnosis of childhood ADHD in someone now the parent of an affected child (Ward et al. 1993). A positive parental history of ADHD is therefore defined as a score of ⩾36 on the 25-item subscale of the WURS.

Definition of Associated Genes and Joint Analysis of Marker Data

Since we previously observed a preponderance of paternal transmission of risk alleles at several of the candidate genes examined, we decided to investigate whether this phenomenon is restricted to ADHD and the combination of genes examined. We defined the “risk” allele for a marker as the allele that demonstrated the highest transmitted:nontransmitted ratio in our full sample, regardless of whether the finding was statistically significant. If the TDT demonstrated overtransmission of the “risk” allele over the other allele(s) at a level of P<.1, that allele was classed as “associated.” This threshold was set deliberately lenient to reduce the type II error rate and would be expected to lead to an underestimate of the size of parent-of-origin effects in our analysis. In addition, we included markers that have been confirmed (by several groups) to be associated with ADHD. We made the assumption that transmission of alleles at each gene is independent of transmission of alleles at other genes and therefore can be combined additively, to test a general paternal versus maternal hypothesis.

Results

Markers at 9 (6 dopaminergic and 3 serotonergic) of the 17 genes examined passed the threshold (TDT P<.1 or associated in several samples) to be considered “associated” with ADHD (table 1): DRD4, DRD5, DAT1, SERT, TPH2, TH, DDC, SNAP-25, and 5HT1B. When the data were stratified on the basis of sex of transmitting parent (table 3), paternal transmission showed, in general, larger odds ratios (ORs) than did maternal transmission. Nominally significant overtransmission of paternal alleles was seen at DRD4, DRD5, DAT1, SERT, and TPH2, and a trend was seen in the case of TH, DDC, SNAP-25, and 5-HT1B. In contrast, no significant association at any of these genes was observed when maternal transmission was considered. This observation implies that association with ADHD is due principally to paternal overtransmission of the risk allele at nine independent loci. This cannot be accounted for by differences in sample size, since the number of maternal observations is comparable to the number of paternal observations across all loci.

Table 3.

Paternal versus Maternal Transmission of ADHD-Associated Genes[Note]

Transmission of ADHD-Associated Genes
Paternal
Maternal
TDT for
TDT for
Associated Allele
Other Alleles
Associated Allele
Other Alleles
Gene (Marker) T NT T NT χ2 P OR T NT T NT χ2 P OR
DRD4 (−616) 40 23 23 40 4.6 .043 1.7 32 19 19 32 3.3 .09 1.7
DRD5 (CA)n 57 29 29 57 9.1 .0034 2.0 54 36 36 54 3.6 .07 1.5
DAT1 (VNTR) 33 18 18 33 4.4 .048 1.8 23 30 30 23 .9 .41 .8
TH (TCAT)n 21 12 12 21 2.5 .16 1.8 28 19 19 28 1.7 .24 1.5
DDC (4-bp ins) 7 2 2 7 2.8 .18 3.5 10 7 7 10 .53 .63 1.4
SNAP-25 (MnlI) 33 22 22 33 2.2 .18 1.5 28 33 33 28 .4 .6 .8
5HT1B (861G) 36 23 23 36 2.9 .11 1.6 29 23 23 29 .73 .46 1.3
SERT (D17S1294) 15 2 2 15 9.9 .002 7.5 9 10 10 9 .05 1.0 .9
TPH2 (rs1843809) 26
 7
 7
26
10.9 .001 3.7 23
12
12
23
3.5 .09 1.9
 Combined TDT 268 138 138 268 41.6 1.5×10-10 1.94 236 189 189 236 5.2 .026 1.26

Note.— Test of paternal versus maternal transmissions: χ2=9.6 (1 df); P=.0019; OR=1.56. T=transmitted; NT=not transmitted.

When data from the “associated” alleles were combined (table 3), highly significant excess paternal transmission was observed (χ2=41.6; P=1.5×10-10; OR=1.94), whereas a marginally significant excess of transmission of maternal alleles was seen (χ2=5.2; P=.026; OR=1.26).

We then tested the hypothesis that there was, overall, greater paternal versus maternal transmission for these genes, versus the null hypothesis that the ratio of transmitted:nontransmitted “risk” alleles is independent of the sex of the parent. The associated paternal versus maternal risk-allele transmissions were compared using a standard χ2 test with 1 df. We found a highly significant difference, attributable to an excess transmission of paternal alleles compared with those of maternal origin (χ2=9.6 [1 df]; P=.0019; OR=1.56) (table 3).

To examine whether the observed paternal overtransmission of the associated alleles might be due to a strong effect at a single locus, we conducted a simple sensitivity analysis (table 4). This was performed by removing one marker at a time and analyzing the remainder as described above. Significant differences between paternal and maternal transmissions remained for all analyses, with P values ranging from .013 (when DAT1 was removed) to .0011 (when DRD4 was removed), which suggests that DAT1 contributed more than any other marker to the combined analysis.

Table 4.

Sensitivity Analysis[Note]

TDT forADHD-AssociatedGenes
Paternal
Maternal
Sample T NT T NT χ2 P
Alla 268 138 236 189 9.6 .0019
No DRD4 (−616) 228 115 204 170 10.6 .0011
No DRD5 (CA)n 211 109 182 153 9.2 .0024
No DAT1 (VNTR) 235 120 213 159 6.1 .013
No TH (TCAT)n 247 126 208 170 9.9 .0016
No DDC (4-bp ins) 261 136 226 182 9.0 .0026
No SNAP-25 (MnlI) 235 116 208 156 7.3 .007
No 5HT1B (861G) 232 115 207 166 9.8 .0017
No SERT (D17S1294) 253 136 227 179 6.9 .0085
No TPH2 (rs1843809) 242 131 213 177 8.3 .0038

Note.— T=transmitted; NT=not transmitted.

a

All nine ADHD-associated genes tested.

The same sets of analyses were repeated with the seven gene/markers “not associated” with ADHD (data not shown), to test whether increased paternal transmission might be a general phenomenon at all loci. The alleles tested were those that showed any increase in transmission over nontransmission (none happened to have equal frequencies for transmission and nontransmission). TDT analysis showed no significant differences in the transmission of the “risk” allele (as defined above) when paternal or maternal origin was considered separately or when compared with each other (χ2=0.68; P=.41).

As a further comparison with our data, we decided to examine genes associated with autism in a similar-sized sample of parent-child trios. Similar to ADHD, boys are more commonly affected with autism than are girls, with an average ratio of 3:1 (Fombonne et al. 2001). We tested the transmission of associated alleles by sex of parent in an autism sample (table 5) to see whether the observed preferential paternal transmission of the associated allele is a phenomenon related to ADHD alone. Three markers/alleles (located on different chromosomes) associated with autism (with use of the same criteria of an uncorrected TDT P<.1) were examined. In a combined analysis, remarkably similar excess transmissions were observed for alleles of paternal (χ2=10; P=.002) and maternal (χ2=10.6; P=.0015 ) origin. Comparison of paternal versus maternal transmissions showed no parent-of-origin effect (χ2=0.01 [1 df]; P=.93).

Table 5.

Transmission of Genes Associated with Autism in the Irish Population[Note]

Transmission of Autism-Associated Genes
Paternal
Maternal
TDT for
TDT for
Associated Allele
Other Alleles
Associated Allele
Other Alleles
Gene (Marker) T NT T NT χ2 P OR T NT T NT χ2 P OR
SERT (ins/del) 21 11 11 21 3.1 .1 1.9 23 12 12 23 3.5 .09 1.9
ITGA4 (rs3770112) 32 16 16 32 5.3 .03 2 32 16 16 32 5.3 .03 2
EN2 (rs3757846) 26
17
17
26
1.9 .2 1.5 20
12
12
20
2 .2 1.6
 Combined TDT 79 44 44 79 10.0 .002 1.8 75 40 40 75 10.6 .0015 1.9

Note.— Test of paternal versus maternal transmissions: χ2=0.01 (1 df); P=.93. T=transmitted; NT=not transmitted.

Discussion

It is evident from the data that there is a significant distortion in the transmission pattern of alleles associated with ADHD, dependent on the sex of the transmitting parent. This phenomenon seems to be ADHD specific and does not generalize to autism, another psychiatric condition with a high male:female ratio. It also appears to be specific to loci associated with the ADHD phenotype, since there is no suggestion of such an effect at alleles not associated with ADHD. There are several possible explanations for these observations.

First, it is necessary to consider whether biased sample selection might account for the findings. Specifically, it could be suggested that the ascertainment of cases of ADHD might depend on the affection status of the parent who, first, brings the child to the attention of the clinical services and, second, agrees to participate in research and brings the child to a test site for assessment. If it is more likely that that parent would be the mother and if having ADHD herself would bias her against taking the steps described above to get her child into the research program, then the sample might be biased toward families in which mothers were unaffected and thus less likely to transmit associated alleles. To address this possibility, the first question to ask is whether the sample contains more affected fathers than affected mothers. Thirty percent of study parents were affected (as determined by the Wender rating scale), 35% of fathers and 25% of mothers (χ2=3.82; P=.051). Therefore, there is a trend of more affected fathers, but this is in keeping with the fact that ADHD is more prevalent in males. There is not the virtual absence of affected mothers that might have been anticipated under the hypothesis of ascertainment bias.

The second question is whether affected parents transmit alleles from associated genes more than do unaffected parents and whether this differs by sex of the transmitting parent. TDT analysis conducted on the number of transmissions analyzed by sex of transmitting parent and by parental history of ADHD shows combined ORs of 2.25 and 1.7 for history-positive and history-negative paternal transmissions, respectively (χ2=1.5; P=.22), and ORs of 1.35 and 1.2 for history-positive and history-negative maternal transmissions, respectively (χ2=0.3; P=.6). Transmissions from history-positive fathers were significantly greater than from history-positive mothers (χ2=5.5; P=.02), and transmissions from history-negative fathers were greater than from history-negative mothers, but not at a significant level (χ2=3.16; P=.075). These data suggest that the excess paternal transmission did not arise from data censoring, because of the bias toward inclusion of unaffected mothers in the sample. However, it should be noted that the method of determining history-positive parents, the WURS questionnaire, may not be a reasonable proxy measure of persistence of ADHD symptoms into adulthood.

Third, could imprinting be involved? Several investigators have observed significant sexual dimorphism in the incidence of psychiatric disorders. Although an increased incidence of autism, ADHD, and antisocial personality disorder is found in males, eating disorder, depression, panic disorder, and phobia are more prevalent in females (Craig et al. 2004). These findings suggest the possibility of a genomic mechanism (such as imprinting) as a contributing factor in these conditions. Imprinting involves the sex-dependent germ-cell epigenetic inactivation of a gene, which results in monoallelic expression in offspring that is parent-of-origin dependent (Murphy and Jirtle 2003). The functional impact of this mechanism can be striking, particularly on brain development. Keverne et al. (1996) suggested that genomic imprinting might facilitate a rapid nonlinear expansion of certain brain regions during development of psychiatric conditions, including ADHD.

Studies of chimeric embryos to assess the roles of the paternal genomes in brain development showed that the contribution of the parthenogenetic/gynogenetic (Pg/Gg duplicated maternal genome) cell to brain development was ∼30%–40%, compared with 5% in the case of the androgenetic cell (Ag duplicated paternal genome) (Barton et al. 1991; Keverne et al. 1996). In addition, the distribution of Ag and Pg cells was found to accumulate in different regions in the brain. Whereas the Ag specifically accumulated in the forebrain, the Pg cells were found predominantly in the cortex and striatum. For control cells, a uniform distribution was observed throughout the brain region (Keverne et al. 1996). This effect is likely due to the deficiency of paternally expressed genes and the double dosage of maternally expressed genes. Imprinted variants, regardless of their parent of origin, are involved in several diseases, including psychiatric and behavioral disorders such as Prader-Willi syndrome (PWS [MIM 176270]) and Angelman syndrome (AS [MIM 105830]). Patients with PWS inherit both copies of imprinted chromosome 15 from their mothers, whereas children who lack portions of maternal chromosome 15q or who possess two copies of paternal chromosome 15 were found to have mental retardation and suffer from seizures as a part of AS (Nicholls 1993; Keverne et al. 1996).

It is well recognized that imprinted genes tend (in general) to cluster in certain chromosomal regions. However, none of the ADHD-associated genes has been mapped to any of these regions. Since ADHD-associated genes map to many different chromosomes, it is unlikely, a priori, that all these genes are imprinted. It remains possible that a generalized disturbance of an imprinting mechanism is a feature of ADHD and that we are detecting linkage disequilibrium to multiple polymorphic methylation target sequences in at least some of the genes showing paternal overtransmission to ADHD-affected cases. However, we are not aware of any molecular evidence to support the involvement of genomic imprinting in ADHD, and the present study does not provide such evidence.

In moving aside from analyses of parental origin of risk alleles, it occurred to us that the method of combining data from multiple associated genes might enable us to test another hypothesis: the proposed differential genetic loading by sex of probands in a disorder with a male:female prevalence ratio such as ADHD. Sex differences in the prevalence of ADHD have been well documented, with boys more likely to develop ADHD than girls (ratio reaching 9:1). Cloninger et al. (1978) hypothesized that the sex differences in ADHD may be explained on the basis that girls require a greater genetic loading to manifest ADHD than do boys. This could be the result of either an inherent risk factor in being male or an inherent protective factor in being female. This hypothesis has been supported recently by Rhee and Waldman (2004). They found that DZ twins or siblings of girls with ADHD had a higher number of symptoms than did twins or siblings of boys with the disorder. In our sample, TDT analysis of transmission by the sex of the child with ADHD (table 6) showed highly significant overtransmission of associated alleles to both girls (χ2=21.9; P=4.7×10-6; OR=2.7) and boys (χ2=27.6; P=1.8×10-7; OR=1.5), which shows that girls require nearly twice the genetic loading of boys (χ2=7; P=.008; OR=1.85). The strongest ORs are found for transmissions from fathers to daughters (OR=3.6), and the weakest from mothers to sons (OR=1.2). This further supports the hypothesis that more genetic loading is necessary for girls to develop ADHD.

Table 6.

Parental Transmission by Sex of Child[Note]

Results of Combined TDT for
Boys
Girls
Associated Allele
Other Alleles
Associated Allele
Other Alleles
Transmission T NT T NT χ2 P OR T NT T NT χ2 P OR
Paternal 232 130 130 232 28.7 1.11×10-7 1.8 39 11 11 39 15.7 9.02×10-5 3.5
Maternal 210
169
169
210
4.4 .04 1.2 35
16
16
35
7.1 .01 2.2
 Total TDT 442 299 299 442 27.6 1.83×10-7 1.5 74 27 27 74 21.9 4.72×10-6 2.7

Note.— Test of paternal versus maternal transmissions for boys: χ2=5.8 (1 df); P=.016; OR=1.44. Test of paternal versus maternal transmissions for girls: χ2=1.1 (1 df); P=.29; OR=1.6. Test of transmissions to boys versus transmissions to girls: χ2=7 (1 df); P=.008; OR=1.85. T=transmitted; NT=not transmitted.

A further option is that these findings could be due to type I error (false-positive result). In general, this may occur as a consequence of small sample size or as a result of sex or ethnic mismatch of patient and control groups. The failure to replicate several association findings in psychiatric disorders has been attributed, at least in part, to the above factors. However, the findings of this study are the results of TDT analysis (a linkage and family-based association) in which the nontransmitted alleles are used as an internal control to avoid population stratification (ethnic and/or sex mismatch). Furthermore, the ADHD-affected nuclear families of the present study are all of Irish origin except for one family in which the father is of Croatian origin. It is less likely, therefore, that these results are chance findings, especially since the examined population is relatively large and the findings appear to be consistent across many genes.

Finally, the findings of this study need to be replicated in other ADHD samples, which should be possible, given the fact that many of the markers included in our study have also been found by several groups to be associated with ADHD.

Acknowledgments

This work was generously supported by the Health Research Board, Dublin (to K.S., N.L., R.S., J.C., and Z.H.), the Wellcome Trust (to Z.H.), the Dublin Molecular Medicine Centre (to Z.H.), and the Hyperactive and Attention Disorder Group Ireland. We thank the families that participated in the study. We also acknowledge the helpful comments and critical evaluation of the manuscript by Professor Ian Craig, Professor Anita Thapar, Professor Mick O’Donovan, and Dr. Lindsey Kent.

Web Resource

The URL for data presented herein is as follows:

  1. Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim/ (for ADHD, DAT1, DBH, DRD4, DRD5, 5HT1B, SNAP25, TPH2, autism, PWS, and AS)

References

  1. Barton SC, Ferguson-Smith AC, Fundele R, Surani MA (1991) Influence of paternally imprinted genes on development. Development 113:679–687 [DOI] [PubMed] [Google Scholar]
  2. Biederman J, Faraone SV (2004) The Massachusetts General Hospital studies of gender influences on attention-deficit/hyperactivity disorder in youth and relatives. Psychiatr Clin North Am 27:225–232 10.1016/j.psc.2003.12.004 [DOI] [PubMed] [Google Scholar]
  3. Biederman J, Faraone SV, Keenan K, Benjamin J, Krifcher B, Moore C, Sprich-Buckminster S, Ugaglia K, Jellinek MS, Steingard R, Spencer T, Norman D, Kolodny R, Kraus I, Perrin J, Keller M, Tsuang MT (1992) Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder: patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples. Arch Gen Psychiatry 49:728–738 [DOI] [PubMed] [Google Scholar]
  4. Biederman J, Mick E, Faraone SV, Braaten E, Doyle A, Spencer T, Wilens TE, Frazier E, Johnson MA (2002) Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry 159:36–42 10.1176/appi.ajp.159.1.36 [DOI] [PubMed] [Google Scholar]
  5. Brophy K, Hawi Z, Kirley A, Fitzgerald M, Gill M (2002) Synaptosomal-associated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD): evidence of linkage and association in the Irish population. Mol Psychiatry 7:913–917 10.1038/sj.mp.4001092 [DOI] [PubMed] [Google Scholar]
  6. Cloninger CR, Christiansen KO, Reich T, Gottesman II (1978) Implications of sex differences in the prevalences of antisocial personality, alcoholism, and criminality for familial transmission. Arch Gen Psychiatry 35:941–951 [DOI] [PubMed] [Google Scholar]
  7. Craig IW, Harper E, Loat CS (2004) The genetic basis for sex differences in human behaviour: role of the sex chromosomes. Ann Hum Genet 68:269–284 10.1046/j.1529-8817.2004.00098.x [DOI] [PubMed] [Google Scholar]
  8. Daly G, Hawi Z, Fitzgerald M, Gill M (1999) Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol Psychiatry 4:192–196 10.1038/sj.mp.4000510 [DOI] [PubMed] [Google Scholar]
  9. Faraone SV, Biederman J, Chen WJ, Milberger S, Warburton R, Tsuang MT (1995) Genetic heterogeneity in attention-deficit hyperactivity disorder (ADHD): gender, psychiatric comorbidity, and maternal ADHD. J Abnorm Psychol 104:334–345 10.1037/0021-843X.104.2.334 [DOI] [PubMed] [Google Scholar]
  10. Faraone SV, Doyle AE, Mick E, Biederman J (2001) Meta-analysis of the association between the dopamine D4 7-repeat allele and attention deficit hyperactivity disorder. Am J Psychiatry 158:1052–1057 10.1176/appi.ajp.158.7.1052 [DOI] [PubMed] [Google Scholar]
  11. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P (2005) Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1313–1323 10.1016/j.biopsych.2004.11.024 [DOI] [PubMed] [Google Scholar]
  12. Fombonne E, Simmons H, Ford T, Meltzer H, Goodman R (2001) Prevalence of pervasive developmental disorders in the British nationwide survey of child mental health. J Am Acad Child Adolesc Psychiatry 40:820–827 10.1097/00004583-200107000-00017 [DOI] [PubMed] [Google Scholar]
  13. Ford T, Goodman R, Meltzer H (2003) The British Child and Adolescent Mental Health Survey 1999: the prevalence of DSM-IV disorders. J Am Acad Child Adolesc Psychiatry 42:1203–1211 10.1097/00004583-200310000-00011 [DOI] [PubMed] [Google Scholar]
  14. Hawi Z, Dring M, Kirley A, Foley D, Kent L, Craddock N, Asherson P, Curran S, Gould A, Richards S, Lawson D, Pay H, Turic D, Langley K, Owen M, O’Donovan M, Thapar A, Fitzgerald M, Gill M (2002) Serotonergic system and attention deficit hyperactivity disorder (ADHD): a potential susceptibility locus at the 5-HT (1B) receptor gene in 273 nuclear families from a multi-centre sample. Mol Psychiatry 7:718–725 10.1038/sj.mp.4001048 [DOI] [PubMed] [Google Scholar]
  15. Hawi Z, Kirley A, Lowe N, Fitzgerald M, Gill M (2003) Recent genetic advances in ADHD and diagnostic and therapeutic prospect. Expert Rev Neurother 3:453–464 10.1586/14737175.3.4.453 [DOI] [PubMed] [Google Scholar]
  16. Kashani J, Chapel JL, Ellis J, Shekim WO (1979) Hyperactive girls. J Oper Psychiatry 10:145–248 [Google Scholar]
  17. Keverne EB, Fundele R, Narasimha M, Barton SC, Surani MA (1996) Genomic imprinting and the differential roles of parental genomes in brain development. Brain Res Dev Brain Res 92:91–100 10.1016/0165-3806(95)00209-X [DOI] [PubMed] [Google Scholar]
  18. Kirley A, Lowe N, Mullins C, McCarron M, Daly G, Waldman I, Fitzgerald M, Gill M, Hawi Z (2004) Phenotype studies of the DRD4 gene polymorphisms in ADHD: association with oppositional defiant disorder and positive family history. Am J Med Genet B Neuropsychiatr Genet 131:38–42 10.1002/ajmg.b.30072 [DOI] [PubMed] [Google Scholar]
  19. Lord C, Risi S, Lambrecht L, Cook EH Jr, Leventhal BL, DiLavore PC, Pickles A, Rutter M (2000) The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 30:205–223 10.1023/A:1005592401947 [DOI] [PubMed] [Google Scholar]
  20. Lord C, Rutter M, Goode S, Heemsbergen J, Jordan H, Mawhood L, Schopler E (1989) Autism diagnostic observation schedule: a standardized observation of communicative and social behavior. J Autism Dev Disord 19:185–212 10.1007/BF02211841 [DOI] [PubMed] [Google Scholar]
  21. Lowe N, Kirley A, Hawi Z, Sham P, Wickham H, Kratochvil CJ, Smith SD, et al (2004a) Joint analysis of the DRD5 marker concludes association with attention-deficit/hyperactivity disorder confined to the predominantly inattentive and combined subtypes. Am J Hum Genet 74:348–356 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lowe N, Kirley A, Mullins C, Fitzgerald M, Gill M, Hawi Z (2004b) Multiple marker analysis at the promoter region of the DRD4 gene and ADHD: evidence of linkage and association with the SNP-616. Am J Med Genet B Neuropsychiatr Genet 131:33–37 10.1002/ajmg.b.30071 [DOI] [PubMed] [Google Scholar]
  23. Maher BS, Marazita ML, Ferrell RE, Vanyukov MM (2002) Dopamine system genes and attention deficit hyperactivity disorder: a meta-analysis. Psychiatr Genet 12:207–215 10.1097/00041444-200212000-00003 [DOI] [PubMed] [Google Scholar]
  24. Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M (1993) Adult outcome of hyperactive boys: educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 50:565–576 [DOI] [PubMed] [Google Scholar]
  25. Murphy SK, Jirtle RL (2003) Imprinting evolution and the price of silence. Bioessays 25:577–588 10.1002/bies.10277 [DOI] [PubMed] [Google Scholar]
  26. Nada-Raja S, Langley JD, McGee R, Williams SM, Begg DJ, Reeder AI (1997) Inattentive and hyperactive behaviors and driving offenses in adolescence. J Am Acad Child Adolesc Psychiatry 36:515–522 10.1097/00004583-199704000-00014 [DOI] [PubMed] [Google Scholar]
  27. Nicholls RD (1993) Genomic imprinting and uniparental disomy in Angelman and Prader-Willi syndromes: a review. Am J Med Genet 46:16–25 10.1002/ajmg.1320460106 [DOI] [PubMed] [Google Scholar]
  28. Poeta LS, Rosa Neto F (2004) Epidemiological study on symptoms of attention deficit/hyperactivity disorder and behavior disorders in public schools of Florianopolis/SC using the EDAH. Rev Bras Psiquiatr 26:150–155 [DOI] [PubMed] [Google Scholar]
  29. Rhee SH, Waldman ID (2004) Etiology of sex differences in the prevalence of ADHD: an examination of inattention and hyperactivity-impulsivity. Am J Med Genet B Neuropsychiatr Genet 127:60–64 10.1002/ajmg.b.20131 [DOI] [PubMed] [Google Scholar]
  30. Rhee SH, Waldman ID, Hay DA, Levy F (1999) Sex differences in genetic and environmental influences on DSM-III-R attention-deficit/hyperactivity disorder. J Abnorm Psychol 108:24–41 10.1037/0021-843X.108.1.24 [DOI] [PubMed] [Google Scholar]
  31. Sheehan K, Lowe N, Kirley A, Mullins C, Fitzgerald M, Gill M, Hawi Z (2005) Tryptophan hydroxylase 2 (TPH2) gene variants associated with ADHD. Mol Psychiatry 10:944–949 10.1038/sj.mp.4001698 [DOI] [PubMed] [Google Scholar]
  32. Spielman RS, McGinnis RE, Ewens WJ (1993) Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506–516 [PMC free article] [PubMed] [Google Scholar]
  33. Thapar A, Holmes J, Poulton K, Harrington R (1999) Genetic basis of attention deficit and hyperactivity. Br J Psychiatry 174:105–111 [DOI] [PubMed] [Google Scholar]
  34. Ward MF, Wender PH, Reimherr FW (1993) The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 150:885–890 [DOI] [PubMed] [Google Scholar]
  35. Wilens TE, Biederman J, Spencer TJ (2002) Attention deficit/hyperactivity disorder across the lifespan. Annu Rev Med 53:113–131 10.1146/annurev.med.53.082901.103945 [DOI] [PubMed] [Google Scholar]

Supplemental References

  1. Barr CL, Feng Y, Wigg K, Bloom S, Roberts W, Malone M, Schachar R, Tannock R, Kennedy JL (2000) Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit hyperactivity disorder. Mol Psychiatry 5:405–409 10.1038/sj.mp.4000733 [DOI] [PubMed] [Google Scholar]
  2. Barr CL, Feng Y, Wigg KG, Schachar R, Tannock R, Roberts W, Malone M, Kennedy JL (2001) 5′-untranslated region of the dopamine D4 receptor gene and attention-deficit hyperactivity disorder. Am J Med Genet 105:84–90 [DOI] [PubMed] [Google Scholar]
  3. Cichon S, Nothen MM, Stober G, Schroers R, Albus M, Maier W, Rietschel M, Korner J, Weigelt B, Franzek E, Wildenauer D, Fimmers R, Propping P (1996) Systematic screening for mutations in the 5′-regulatory region of the human dopamine D1 receptor (DRD1) gene in patients with schizophrenia and bipolar affective disorder. Am J Med Genet 67:424–428 [DOI] [PubMed] [Google Scholar]
  4. Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M (1997) Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry 2:311–313 10.1038/sj.mp.4000290 [DOI] [PubMed] [Google Scholar]
  5. Hawi Z, McCabe U, Straub RE, O’Neill A, Kendler KS, Walsh D, Gill M (1998) Examination of new and reported data of the DRD3/MscI polymorphism: no support for the proposed association with schizophrenia. Mol Psychiatry 3:150–155 10.1038/sj.mp.4000362 [DOI] [PubMed] [Google Scholar]
  6. Hawi Z, Millar N, Daly G, Fitzgerald M, Gill M (2000) No association between catechol-O-methyltransferase (COMT) gene polymorphism and attention deficit hyperactivity disorder (ADHD) in an Irish sample. Am J Med Genet 96:282–284 [DOI] [PubMed] [Google Scholar]
  7. Speight G, Turic D, Austin J, Hoogendoorn B, Cardno AG, Jones L, Murphy KC, Sanders R, McCarthy G, Jones I, McCandless F, McGuffin P, Craddock N, Owen MJ, Buckland P, O’Donovan MC (2000) Comparative sequencing and association studies of aromatic L-amino acid decarboxylase in schizophrenia and bipolar disorder. Mol Psychiatry 5:327–331 10.1038/sj.mp.4000717 [DOI] [PubMed] [Google Scholar]
  8. Stober G, Nothen MM, Porzgen P, Bruss M, Bonisch H, Knapp M, Beckmann H, Propping P (1996) Systematic search for variation in the human norepinephrine transporter gene: identification of five naturally occurring missense mutations and study of association with major psychiatric disorders. Am J Med Genet 67:523–532 [DOI] [PubMed] [Google Scholar]
  9. Turic D, Langley K, Mills S, Stephens M, Lawson D, Govan C, Williams N, Van Den Bree M, Craddock N, Kent L, Owen M, O’Donovan M, Thapar A (2004) Follow-up of genetic linkage findings on chromosome 16p13: evidence of association of N-methyl-d aspartate glutamate receptor 2A gene polymorphism with ADHD. Mol Psychiatry 9:169–173 10.1038/sj.mp.4001387 [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES